Vitamin B6 supplements: the TGA rules and the 2027 change

In short

  • In a listed medicine, vitamin B6 comes as pyridoxine hydrochloride, pyridoxal 5-phosphate or pyridoxal 5-phosphate monohydrate. The maximum daily dose is 100 mg of pyridoxine for adults, and less for children and teenagers.
  • Above 10 mg of pyridoxine a day, the label must carry a warning to stop taking it and see a healthcare practitioner if tingling, burning or numbness occurs.
  • From 1 June 2027, oral products giving more than 50 mg and up to 200 mg per recommended daily dose become Pharmacist Only (Schedule 3). At 50 mg or less, they stay in general retail.
  • The TGA counted at least 125 medicines in that range, 116 of them listed. Their ARTG listings will be cancelled: to stay on sale, they need to be registered and their labels updated.
  • The TGA's reason is peripheral neuropathy: it says the risk can't be excluded below 50 mg a day.

Vitamin B6 in a listed medicine now

The Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026, in force since 16 October 2026, permits three forms (permissible ingredients): pyridoxal 5-phosphate (item 4239), pyridoxal 5-phosphate monohydrate (item 4240) and pyridoxine hydrochloride (item 4241). Pyridoxine is a mandatory component of each, and the amount of pyridoxine is worked out from the ingredient's molecular weight.

Each entry sets the same limits. The maximum recommended daily dose of the medicine must not provide more than:

Age Maximum pyridoxine a day
1 to 3 years 15 mg
4 to 8 years 20 mg
9 to 13 years 30 mg
14 to 18 years 40 mg
19 years and older 100 mg

If the maximum recommended daily dose provides more than 10 mg of pyridoxine, the label must carry this warning:

"WARNING - Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. [Contains vitamin B6]."

The TGA says this warning has applied to products above 10 mg a day since 1 March 2022. The limit counts the whole daily dose, so B6 from every ingredient in the formula is added up, and a formula designed for adults is checked against the lower limits if it is presented for teenagers or children (supplement labelling).

The change from 1 June 2027

On 25 November 2025 the TGA published its final decision to amend the Poisons Standard for pyridoxine, pyridoxal and pyridoxamine (vitamin B6), confirming its interim decision of June 2025. From 1 June 2027:

  • 50 mg or less per recommended daily dose, by mouth: unscheduled, so general retail, as now.
  • More than 50 mg and up to 200 mg per recommended daily dose, by mouth: a new Schedule 3 entry, so Pharmacist Only.
  • More than 200 mg: the TGA says these products will continue to require a prescription.

The decision gives its reasons. The 50 mg cut-off matches the adult upper level of intake set by the NHMRC, and the TGA concluded there is sufficient evidence that peripheral neuropathy may occur in some people at 50 mg a day or lower. As of 31 October 2025 there were 250 reports of peripheral neuropathy and related terms for products containing vitamin B6 on the TGA's Database of Adverse Event Notifications, 208 of them made since 1 January 2023. The decision notes the NHMRC is reviewing the upper level, expected in early 2027, and that the limits will be looked at again if it changes. The TGA's medicine safety update says the risk "cannot be excluded for doses less than 50 mg/day".

What it means for a listed medicine

The TGA's decision found at least 125 medicines providing more than 50 mg but less than 200 mg per maximum daily dose, 116 of them listed complementary medicines. It says that to stay on the Australian market they will need to be registered on the ARTG and their labels updated, and its safety update says those listed entries will be cancelled. The decision also says the Permissible Ingredients Determination will need to be amended to match, and that warning statements may be strengthened later.

A registered medicine (AUST R) is fully assessed by the TGA before it is sold (listed or registered). So a brand with a product above 50 mg a day has two ways forward: reformulate to 50 mg or less and stay listed, or register the product and supply it as a Pharmacist Only medicine.

What a brand with B6 in its range should do

  • Add up the B6 in every product. Take the maximum recommended daily dose and every ingredient that supplies pyridoxine, including B complexes, multivitamins, magnesium and energy blends, and calculate the pyridoxine from each form's molecular weight.
  • Above 50 mg a day, decide early. A reformulation means new evidence, label and stability work, and a registration waits on the TGA's evaluation, so both are worth starting well before June 2027 (reformulating a supplement).
  • Check the label whatever the dose. Above 10 mg a day the warning is required now, and the TGA has said warning statements may be strengthened. A product kept at or below 50 mg still needs its label checked against the current rules at each reprint.
  • Watch the Determination. The Permissible Ingredients Determination is to be amended to reflect the scheduling change, so check the B6 entries again before you lodge a new listing.

From our records

  • EverLeanBody: a premium daily capsule for women 35 and over, built on affron® saffron extract with L-theanine, lemon balm and active-form B vitamins. We designed the formula, built the claims evidence, secured the TGA listing, drafted the label and set up a 24-month stability program: 5.8 months from signed brief to dispatch.
  • Arxi's prenatal chewable: B vitamins and selenium are bitter and smell strongly, so after a liquid drop that wasn't stable and couldn't be taste-masked, we moved the prenatal to a two-a-day chewable with Rocoat® coated B vitamins to tame the taste. Our label review caught two errors before print.

Questions

Frequently asked questions

No. From 1 June 2027, oral products giving more than 50 mg and up to 200 mg of vitamin B6 per recommended daily dose become Pharmacist Only medicines. Products at 50 mg or less stay in general retail.

The TGA says their ARTG listings will be cancelled. To stay on sale, they need to be registered on the ARTG and their labels updated, or the formula can be changed to 50 mg or less.

When its maximum recommended daily dose provides more than 10 mg of pyridoxine. The label must say to stop taking it and see a healthcare practitioner as soon as possible if tingling, burning or numbness occurs.

100 mg of pyridoxine a day for adults, under the Permissible Ingredients Determination, and less for children and teenagers: 15 mg at 1 to 3 years, 20 mg at 4 to 8, 30 mg at 9 to 13 and 40 mg at 14 to 18.

Peripheral neuropathy. The TGA concluded it may occur in some people at 50 mg a day or lower, and the 50 mg cut-off matches the NHMRC's adult upper level of intake.

Sources

General information, checked against these sources on 16 November 2026. It isn't advice on a particular product. Our work is from Take Friday Off's records.

Close your laptop on Thursday night and relax.

Your launch keeps moving, in hands that care about it as much as you do. That's The Friday Feeling™.

15 minutes, no obligation, and a clear next step either way.

Questions first? Read the questions brands ask us